Product image of Indium (In111) Chloride Curium Netherlands (Indium (111in)) supplied by GNH India

Indium (In111) Chloride Curium Netherlands

Active Ingredient:
Indium (111in)
Origin:
EU

Indium (In111) Chloride Curium Netherlands (Indium (111in))

Indium-111 chloride, the active ingredient in Indium (In111) Chloride Curium Netherlands, is a radiopharmaceutical presented as a solution for injection for intravenous use. It is employed to image infection, inflammation, bone marrow activity, and tumor tissue in adult patients.

GNH India supplies Indium (In111) Chloride Curium Netherlands as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, oncology centres, and clinics worldwide.

Manufacturer / TM Owner

Curium Netherlands B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Indium-111 chloride is employed in nuclear medicine imaging to localize infection, inflammation, bone marrow activity, and tumor tissue.

  • Localization of infection and inflammation: enables scintigraphic detection of infectious foci and inflammatory lesions.
  • Bone marrow imaging: visualizes marrow distribution and activity for diagnostic assessment.
  • Tumor and lymphoma imaging: assists in identifying malignant lesions and evaluating disease extent.
  • Leukocyte labeling for infection detection: tags white blood cells to pinpoint sites of infection.

How It Works

  • Indium-111 chloride acts as a radioactive tracer that emits gamma photons detectable by scintigraphic cameras. After intravenous injection, it binds to plasma proteins and is taken up by reticuloendothelial cells, bone marrow, and certain tumor cells, allowing high‑resolution imaging of infection, inflammation, marrow activity, and malignant tissue.

Side Effects

Adverse reactions may occur following administration of Indium-111 chloride.

Common Side Effects

  • Injection site pain: mild discomfort at the puncture site.
  • Transient flushing: brief feeling of warmth.
  • Mild nausea: occasional stomach upset.
  • Headache: short‑lasting headache.

Serious or Rare Side Effects

  • Allergic reaction (anaphylaxis): severe hypersensitivity requiring immediate care.
  • Radiation‑induced skin injury: localized skin changes at high exposure.
  • Bone marrow suppression (rare): transient decrease in blood cell counts.
  • Severe hypotension: sudden drop in blood pressure post‑injection.

Precautions & Warnings

Prior to use, clinicians should consider several safety measures.

  • Pregnancy: use only if the diagnostic benefit outweighs potential fetal radiation risk.
  • Breastfeeding: discontinue nursing or assess risk versus benefit.
  • Renal impairment: evaluate clearance and consider dose adjustment.
  • Concurrent radiopharmaceuticals: avoid overlapping imaging studies to prevent excess radiation.
  • Radiation safety: follow ALARA principles to protect staff and patients.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Indium-111 chloride may interact with other agents used in diagnostic or therapeutic settings.

Major Interactions (Avoid)

  • Concurrent gamma‑emitting radiopharmaceuticals: overlapping radiation fields can compromise image quality and increase dose.
  • Bone‑marrow suppressive chemotherapy: may exacerbate hematologic toxicity.

Moderate Interactions (Monitor Closely)

  • Iodinated contrast agents used in CT: may affect image interpretation.
  • Antihistamines: could mask mild allergic responses.
  • Beta‑blockers: may influence hemodynamic response to injection.

Frequently Asked Questions

Indium-111 chloride is a radiopharmaceutical used in nuclear medicine to image sites of infection, inflammation, bone marrow activity, and malignant tumors. By emitting gamma photons, it enables high‑resolution scintigraphic scans that help clinicians locate disease foci and assess disease extent.

After intravenous injection, Indium-111 chloride binds to plasma proteins and is taken up by reticuloendothelial cells, bone marrow, and certain tumor cells. The isotope emits gamma photons that are captured by a gamma camera, producing detailed images of the targeted tissues.

The prescribed activity of Indium-111 chloride is determined by the ordering physician based on the specific imaging protocol, patient weight, and clinical indication. Dosing is individualized and should follow the radiopharmacy’s preparation guidelines.

Safety data are limited; Indium-111 chloride should be used in pregnancy only when the diagnostic benefit justifies potential fetal radiation exposure. Breastfeeding mothers should discuss risks with their physician, as the radiotracer may be excreted in milk.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Compared with technetium‑99m agents, Indium-111 offers a longer half‑life and higher energy gamma emissions, allowing delayed imaging and better visualization of certain tumors and bone marrow. However, it delivers a higher radiation dose, so selection depends on the clinical question and patient considerations.

Indium-111 chloride must be stored refrigerated at 2‑8 °C, protected from light, and never frozen or shaken. Handling should be performed by trained personnel using radiation safety measures, including shielding, monitoring, and proper waste disposal.

The product is supplied as a sterile solution for injection and is administered intravenously by a qualified healthcare professional. Administration is typically performed in a controlled radiology suite with appropriate radiation protection for staff and the patient.

Serious risks include allergic reactions such as anaphylaxis, radiation‑induced skin injury, and rare bone‑marrow suppression. Patients should be monitored for signs of hypersensitivity, unexpected bruising or bleeding, and any acute changes in vital signs during and after the injection.

Indium-111 chloride is contraindicated in patients with known severe hypersensitivity to the product, those who are pregnant unless absolutely necessary, and individuals who have recently received other high‑dose radiopharmaceuticals that could result in excessive cumulative radiation exposure.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.